eXoZymes (EXOZ) Action Cours

Invizyne Technologies Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Monrovia California, California and currently employs 29 full-time employees. The company went IPO on 2024-11-13. Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The firm's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The firm is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).